Release no. 1/2012

Copenhagen and Oslo, 6th March, 2012, 2012-03-06 10:40 CET (GLOBE NEWSWIRE) --
Affitech A/S (NASDAQ OMX: AFFI) updates its financial calendar 2012. The date
for the Annual General Meeting 2012 has been changed from Thursday 26th April,
2012 to Friday 27thApril, 2012. Affitech also announces to its shareholders
that the deadline for proposals for the Annual General Meeting is Friday 16th
March, 2012.


The financial calendar for 2012 is as follows:


16th March, 2012 Deadline for proposals for the Annual
General Meeting, 2012

29th March, 2012 Financial Result 2011

27th April, 2012 Annual General Meeting

24th May, 2012 Interim financial report for 1st quarter
2012

30th August, 2012 Interim financial report for 2nd quarter 2012

22nd November, 2012 Interim financial report for 3rd quarter 2012





About Affitech

Affitech AS is a publicly traded (NASDAQ OMX Copenhagen) human therapeutic
antibody company based in Copenhagen, Denmark with R&D facilities in Oslo,
Norway. The company utilizes a range of proprietary antibody technologies for
the discovery of fully human antibodies for application in oncology,
inflammation and other disease areas. CBAS™ (Cell Based Antibody Selection) is
Affitech’s premier discovery engine for the isolation of lead antibodies to
cell surface molecules in situ. Several of the Company's proprietary product
candidates were generated by CBAS™. Further information is available at
www.affitech.com.




For more information please contact

Randi Krogsgaard, Director IR & Communications

Tel # +45 2320 1001, e-mail: [email protected]

120306_update financial calendar_pr-1_uk.pdf